Infectious Disease
If you don't find a topic or disease in our list of publications, please call (toll free in the U.S.): +1-866-296-8352 or email us so that we can guide you to related or upcoming coverage or discuss a customized project through our consulting group.
Infectious diseases represent a highly diverse and dynamic therapeutic area in which the unrelenting emergence of drug resistance drives a need for innovative new therapeutics and vaccines. Decision Resources’ infectious disease portfolio contains the most cutting-edge analysis and insight across all the major drug sectors (antibacterials, antivirals, antifungals, and vaccines).
Upcoming infectious disease reports:
- Hepatitis C Virus
- Human Immunodeficiency Virus
- Gram-Negative Infections
- Methicillin-Resistant Staphylococcus Aureus
- Community-Acquired Pneumonia
- Hospital-Acquired Pneumonia
Round-up
Register to receive Decision Resources' round-up, a summary email of the company's latest research, products, and special offers.
Decision Resources Group companies include: